J. Patrick McGovren

2.2k total citations
42 papers, 1.9k citations indexed

About

J. Patrick McGovren is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, J. Patrick McGovren has authored 42 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Organic Chemistry. Recurrent topics in J. Patrick McGovren's work include Cancer therapeutics and mechanisms (17 papers), Cancer Treatment and Pharmacology (10 papers) and Pharmacogenetics and Drug Metabolism (5 papers). J. Patrick McGovren is often cited by papers focused on Cancer therapeutics and mechanisms (17 papers), Cancer Treatment and Pharmacology (10 papers) and Pharmacogenetics and Drug Metabolism (5 papers). J. Patrick McGovren collaborates with scholars based in United States, Malaysia and Canada. J. Patrick McGovren's co-authors include Robert C. Kelly, Laurence H. Hurley, Martha A. Warpehoski, T F Dekoning, William C. Krueger, Li H. Li, Ilse Gebhard, Vincent L. Reynolds, Y.‐H. Hui and K.I. Ahammadsahib and has published in prestigious journals such as Science, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

J. Patrick McGovren

42 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Patrick McGovren United States 23 1.2k 569 409 269 199 42 1.9k
Jacqueline Plowman United States 27 1.8k 1.4× 797 1.4× 682 1.7× 299 1.1× 153 0.8× 66 2.9k
Eun Lee South Korea 25 558 0.5× 1.2k 2.1× 111 0.3× 257 1.0× 172 0.9× 105 2.0k
Kazuo Kanai Japan 23 516 0.4× 749 1.3× 104 0.3× 128 0.5× 286 1.4× 93 1.6k
Mark F. Bean United States 20 1.1k 0.9× 933 1.6× 52 0.1× 296 1.1× 82 0.4× 29 2.5k
Robert M. Snapka United States 22 1.1k 0.9× 308 0.5× 443 1.1× 90 0.3× 68 0.3× 44 1.5k
John K. Buolamwini United States 29 1.9k 1.6× 755 1.3× 728 1.8× 156 0.6× 52 0.3× 75 3.1k
Nobuyuki Hamanaka Japan 23 798 0.7× 607 1.1× 223 0.5× 335 1.2× 157 0.8× 119 1.8k
Ruth I. Geran United States 9 624 0.5× 225 0.4× 318 0.8× 126 0.5× 57 0.3× 12 1.3k
Louis Grenier Canada 22 1.6k 1.3× 689 1.2× 552 1.3× 248 0.9× 28 0.1× 42 2.5k
TSUTOMU SAWA Japan 26 1.2k 1.0× 888 1.6× 345 0.8× 906 3.4× 36 0.2× 110 2.3k

Countries citing papers authored by J. Patrick McGovren

Since Specialization
Citations

This map shows the geographic impact of J. Patrick McGovren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Patrick McGovren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Patrick McGovren more than expected).

Fields of papers citing papers by J. Patrick McGovren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Patrick McGovren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Patrick McGovren. The network helps show where J. Patrick McGovren may publish in the future.

Co-authorship network of co-authors of J. Patrick McGovren

This figure shows the co-authorship network connecting the top 25 collaborators of J. Patrick McGovren. A scholar is included among the top collaborators of J. Patrick McGovren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Patrick McGovren. J. Patrick McGovren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brier, Michael E., et al.. (2010). Pharmacokinetics of Dexrazoxane in Subjects With Impaired Kidney Function. The Journal of Clinical Pharmacology. 51(5). 731–738. 5 indexed citations
2.
Hurwitz, Herbert I., Roger B. Cohen, J. Patrick McGovren, et al.. (2006). A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 59(1). 139–147. 13 indexed citations
3.
Yamada, Yasuhide, Tomohide Tamura, Noboru Yamamoto, et al.. (2005). Phase I and pharmacokinetic study of edotecarin, a novel topoisomerase I inhibitor, administered once every 3 weeks in patients with solid tumors. Cancer Chemotherapy and Pharmacology. 58(2). 173–182. 15 indexed citations
4.
Meyerhardt, Jeffrey A., et al.. (2004). Relationship of Baseline Serum Bilirubin to Efficacy and Toxicity of Single-Agent Irinotecan in Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology. 22(8). 1439–1446. 44 indexed citations
5.
Ahammadsahib, K.I., Robert M. Hollingworth, J. Patrick McGovren, Y.‐H. Hui, & Jerry L. McLaughlin. (1993). Mode of action of bullatacin: A potent antitumor and pesticidal Annonaceous acetogenin. Life Sciences. 53(14). 1113–1120. 171 indexed citations
6.
Bhuyan, B. K., et al.. (1992). Lethality, DNA alkylation, and cell cycle effects of adozelesin (U-73975) on rodent and human cells.. PubMed. 52(20). 5687–92. 29 indexed citations
7.
Li, Li H., Robert C. Kelly, Martha A. Warpehoski, et al.. (1991). Adozelesin, a selected lead among cyclopropylpyrroloindole analogs of the DNA-binding antibiotic, CC-1065. Investigational New Drugs. 9(2). 137–148. 66 indexed citations
8.
Warpehoski, Martha A., Ilse Gebhard, Robert C. Kelly, et al.. (1988). Stereoelectronic factors influencing the biological activity and DNA interaction of synthetic antitumor agents modeled on CC-1065. Journal of Medicinal Chemistry. 31(3). 590–603. 117 indexed citations
9.
Hurley, Laurence H., J. Patrick McGovren, Martha A. Warpehoski, et al.. (1988). Molecular basis for sequence-specific DNA alkylation by CC-1065. Biochemistry. 27(10). 3886–3892. 120 indexed citations
10.
Hurley, Laurence H., J. Patrick McGovren, Martha A. Warpehoski, et al.. (1988). Reaction of CC-1065 and select synthetic analogs with DNA. Biochemical Pharmacology. 37(9). 1795–1796. 2 indexed citations
11.
Wierenga, Wendell, B. K. Bhuyan, Robert C. Kelly, et al.. (1986). Antitumor activity and biochemistry of novel analogs of the antibiotic, CC-1065. Advances in Enzyme Regulation. 25. 141–155. 34 indexed citations
12.
McGovren, J. Patrick, Robert J. Belt, Sarah A. Taylor, et al.. (1985). Pharmacokinetic and biochemical studies on acivicin in phase I clinical trials.. PubMed. 45(9). 4460–3. 10 indexed citations
13.
Weiss, Geoffrey R., et al.. (1982). Phase I and pharmacological study of acivicin by 24-hour continuous infusion.. PubMed. 42(9). 3892–5. 30 indexed citations
14.
Clarke, Graham W., et al.. (1981). Antitumor activity and acute toxicity of cc-1065 (nsc-298223) in the mouse. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 4 indexed citations
15.
McGovren, J. Patrick, et al.. (1981). Sex- and age-related mouse toxicity and disposition of the amino acid antitumor agent, acivicin.. Journal of Pharmacology and Experimental Therapeutics. 216(3). 433–440. 15 indexed citations
16.
McGovren, J. Patrick, et al.. (1979). Chronic cardiotoxicity studies in rabbits with 7-con-O-methylnogarol, a new anthracycline antitumor agent.. PubMed. 39(12). 4849–55. 27 indexed citations
17.
Wiley, Paul F., et al.. (1979). Mammalian and microbial cell-free conversion of anthracycline antibiotics and analogs.. The Journal of Antibiotics. 32(2). 141–147. 5 indexed citations
18.
Lubawy, William C., H.B. Kostenbauder, & J. Patrick McGovren. (1978). In vivo and in vitro alteration of nicotine metabolism by the major metabolite of phenytoin.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 19(2). 257–69. 1 indexed citations
19.
Kostenbauder, H.B., Robert P. Rapp, J. Patrick McGovren, et al.. (1975). Bioavailability and single‐dose pharmacokinetics of intramuscular phenytoin. Clinical Pharmacology & Therapeutics. 18(4). 449–456. 54 indexed citations
20.
McGovren, J. Patrick, et al.. (1974). Radioimmunoassay in pharmacy practice.. PubMed. 31(8). 763–70. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacqueline Plowman Breakdown of academic impact, for papers by Eun Lee Breakdown of academic impact, for papers by Kazuo Kanai Breakdown of academic impact, for papers by Mark F. Bean Breakdown of academic impact, for papers by Robert M. Snapka Breakdown of academic impact, for papers by John K. Buolamwini Breakdown of academic impact, for papers by Nobuyuki Hamanaka Breakdown of academic impact, for papers by Ruth I. Geran Breakdown of academic impact, for papers by Louis Grenier Breakdown of academic impact, for papers by TSUTOMU SAWA
Rankless by CCL
2026